Retacrit

Active Ingredient(s): Epoetin Alfa-epbx
FDA Approved: * May 15, 2018
Pharm Company: * HOSPIRA INC
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Retacrit Overview

Epoetin alfa (rINN) /po.tn/ is a human erythropoietin produced in cell culture using recombinant DNA technology.[1] Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is manufactured and marketed by Amgen under the trade name Epogen. Johnson & Johnson subsidiary Janssen Biotech (formerly Ortho Biotech Produ...

Read more Retacrit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Epoetin_alfa

Recent Retacrit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Epoetin Alfa-epbx
  • Injection: 10,000units/ml, 10000unit/ml, 2,000units/ml, 20000unit/ml, 2000unit/ml, 3,000units/ml, 3000unit/ml, 4,000units/ml, 40,000units/ml, 40000unit/ml, 4000unit/ml
  • Vial: 10,000u/ml, 2,000u/ml, 20,000/ml, 20,000u/2ml, 3,000u/ml, 4,000u/ml, 40,000u/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Retacrit: (9 results)

Sorted by National Drug Code
  • 0069-1305 Retacrit 2000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-1306 Retacrit 3000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-1307 Retacrit 4000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-1308 Retacrit 10000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-1309 Retacrit 40000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
  • 59353-002 Retacrit 2000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Vifor (International) Inc.
  • 59353-003 Retacrit 3000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Vifor (International) Inc.
  • 59353-004 Retacrit 4000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Vifor (International) Inc.
  • 59353-010 Retacrit 10000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution by Vifor (International) Inc.

Other drugs which contain Epoetin Alfa-epbx or a similar ingredient: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 July 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.